Subscribe
  • Home
  • Issues
    • Latest Issue
    • Issue Archive
    • Special Issues
      • 2022 Midyear Review: Non–Small-Cell Lung Cancer
      • 2022 Oncology Biosimilar Guide to Patient Support Services
      • 2022 Breast Cancer Guide to Patient Support Services
  • Browse By Topic
    • Practice Management
    • Financial Management
    • Reimbursement
    • Health Policy
    • Quality Care
    • ICD Codes
    • Survivorship
    • FDA Approvals, News & Updates
    • In the News
  • Guide to Patient Support Services
    • Index
    • Introduction
    • 2023 Spotlight: Amgen
  • Conference Correspondent
    • ASCO 2022 - Wrap Up
    • NSCLC IO 2022 - Midyear Review
    • SABCS 2021 Wrap-Up
    • Dual IO 2021 Year in Review
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Webinars
    • Rapid Reactions
    • In the News
    • Quick Quiz
    • Multiple Myeloma Monthly Minutes
    • Melanoma Monthly Minutes
    • Press Releases
    • Women's Health Monthly Minutes
    • Lung Cancer Monthly Minutes
    • Gastrointestinal Cancer Monthly Minutes
  • Issues
  • 2015
  • May 2015, Vol 5, No 4

May 2015, Vol 5, No 4

FDA-Approved Medications Used for the Treatment of Leukemia
ICD Codes
The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of leukemia. Read More ›

Akynzeo (Netupitant and Palonosetron), a Dual-Acting Oral Agent, Approved by the FDA for the Prevention of Chemotherapy-Induced Nausea and Vomiting
By Lisa A. Raedler, PhD, RPh
Drug Updates
Read More ›

Trials Under Way for Patients with Melanoma
Clinical Trials Tracker
Read More ›

Seven Steps to Finding the Right Financial Advisor
By W. Ben, Utley, CFP; Lawrence B. Keller, CFP, CLU, ChFC, RHU, LUTCF
Financial Management, Practice Management, Practice Management
Read More ›

Rest in Peace, SGR
By Leah Ralph
Read More ›

Sunitinib Associated with Higher Costs Compared with Pazopanib in Patients with RCC
By Chase Doyle
Drug Updates
Read More ›

Federal Government Outlines Stage 3 of Meaningful Use
By Rosemary Frei, MSc
Reimbursement
Read More ›

Waiting for the Carrot? It May Take a While
By Dawn Holcombe, MBA, FACMPE, ACHE
From the Editor
Read More ›

The Nurse Practitioner’s Role in the Practice
By Peggy Barton, RN
Practice Management
Read More ›

340B Rules Remain in Flux
By Rosemary Frei, MSc
Read More ›

Page 1 of 2

  • 1
  • 2
View the Latest Issue of OPM
View the Latest Issue
Read Issue

Top Trending Articles

1.
Specialty Carve-Out Models Cost Patients and Employers More Than They Disclose
By Dawn Holcombe, MBA, FACMPE, ACHE
2.
Best Practices: Education for Patients with Advanced NSCLC Treated with Immune Checkpoint Inhibitors
By Marianne Davies, DNP, ACNP, AOCNP, FAAN; Shawn Perkins, RN, BSN, OCN
3.
Dexamethasone-Sparing Regimen Safe and Effective in Frail Patients with Multiple Myeloma
By William King
  • Home
  • Issues
    • Latest Issue
    • Issue Archive
    • Special Issues
      • 2022 Midyear Review: Non–Small-Cell Lung Cancer
      • 2022 Oncology Biosimilar Guide to Patient Support Services
      • 2022 Breast Cancer Guide to Patient Support Services
  • Browse By Topic
    • Practice Management
    • Financial Management
    • Reimbursement
    • Health Policy
    • Quality Care
    • ICD Codes
    • Survivorship
    • FDA Approvals, News & Updates
    • In the News
  • Guide to Patient Support Services
    • Index
    • Introduction
    • 2023 Spotlight: Amgen
  • Conference Correspondent
    • ASCO 2022 - Wrap Up
    • NSCLC IO 2022 - Midyear Review
    • SABCS 2021 Wrap-Up
    • Dual IO 2021 Year in Review
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Webinars
    • Rapid Reactions
    • In the News
    • Quick Quiz
    • Multiple Myeloma Monthly Minutes
    • Melanoma Monthly Minutes
    • Press Releases
    • Women's Health Monthly Minutes
    • Lung Cancer Monthly Minutes
    • Gastrointestinal Cancer Monthly Minutes
CONNECT
Subscribe
  • About
    • About OPM
    • Mission Statement
    • Editorial Board
    • AOPM
    • Contact
  • Contribute
    • Submit a Manuscript
    • Author Guidelines
  • Connect
    • Join Us on LinkedIn
Sign Up for Oncology News

Subscribe to recieve the free, monthly OPM print publication and OPM weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.